ESTRO35 Programme Book

SATURDAY 30 APRIL 2016

09:35 > Importance of b-value selection and geometrical accuracy in DW-MRI for radiotherapy Speaker: M. Lambrecht (Belgium)

SP-0026

Joint Symposium ESTRO-IAEA JOINT ESTRO-IAEA EFFORTS ON DOSIMETRY, QA AND AUDIT FOR ADVANCED TREATMENT TECHNIQUES 08:45 - 10:00 | ROOM 500 Advanced treatment techniques present increasingly complex challenges for commissioning, do- simetry, QA and verification. This joint ESTRO-IAEA symposium reviews activities in some key areas supporting the clinical implementation, evaluation, assurance and development of advanced radio- therapy methods. It focusses on i) the new small/non-standard field dosimetry CoP, to ensure consist- ent dosimetry in these situations; ii) discussion of small field dosimetry uncertainties for significance/ acceptability in VMAT/IMRT, considering whether current practice and tools for patient specific QA can detect such uncertainties; and iii) recent developments and results in the IAEA external audit sys- tem and their application and lessons for advanced radiotherapy. Chair: D.I. Thwaites (Australia) Chair: J. Izewska (Austria) 08:45 > New IAEA-AAPM Code of Practice for dosimetry of small photon fields used in external beam radiotherapy Speaker: H. Palmans (UK) 09:10 > Which dosimetric uncertainties in small fields are clinically acceptable for IMRT/VMAT? Speaker: W. Lechner (Austria) 09:35 > IAEA external audits for advanced radiotherapy - lessons learnt and their relevance for industrialised countries Speaker: J. Izewska (Austria)

SP-0027

SP-0028

SP-0029

Symposium STRATEGIES FOR TREATMENT PLANNING

08:45 - 10:00 | ROOM 3 Chair: A. Duffton (UK) Co-Chair: F. Fellin (Italy)

08:45 > Comparisons of treatment planning with photons and protons Speaker: M. Enmark (Sweden)

SP-0030

09:10 > When to re-plan: a practical perspective Speaker: B. Bak (Poland)

SP-0031

SCIENTIFIC PROGRAMME | PROGRAMME AND EXHIBITION GUIDE

63